Gem Aromatics Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹309 - ₹325
- Lot size
- 46 shares
- Issue amount
- ₹451.25 cr
- Total subscription
- 50.41×
- Opens
- 19 Aug 2025
- Closes
- 21 Aug 2025
- Allotment
- 22 Aug 2025
- Listing
- 26 Aug 2025
Offer at a glance
Issue overview
- Issue size
- 1,38,84,615 shares
- Face value
- ₹2 Per Share
- Minimum investment
- ₹14,214
- Fresh issue
- ₹175 cr
- Offer for sale
- ₹276.25 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,950
- Issue type
- Bookbuilding IPO
- Shares before issue
- 4,68,52,523
- Shares after issue
- 5,22,37,138
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 46 | ₹14,950 |
| sHNI | 14 | 644 | ₹2,09,300 |
| bHNI | 67 | 3,082 | ₹10,01,650 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| HNIs (10L+) | 2,156 | 21,559 |
| HNIs (2-10L) | 1,078 | 42,997 |
| RETAIL | 1,05,644 | 9,32,565 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 90.25 | 4,851.94 |
| RETAIL | 157.94 | 3,646.61 |
| NIB | 67.69 | 7,396.05 |
| HNIs 2+ | 22.56 | 2,092.54 |
| HNIs 10+ | 45.13 | 5,303.51 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 11.39 | 10.69 | 9.53 |
| ROE | 18.8 | 21.73 | 24.88 |
| ROCE | 16.02 | 21.1 | 22.85 |
| RONW | 18.8 | 21.73 | 24.88 |
| PRE IPO(PE) | 28.52 | 0 | 0 |
| POST IPO(PE) | 31.8 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Founded in October 1997, Gem Aromatics Limited is an Indian manufacturer of specialty ingredients like essential oils, aroma chemicals, and value-added derivatives, with over 20 years of experience. Its 70 products, grouped into mint derivatives, clove derivatives, phenol, and other natural or synthetic ingredients, are used in oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness, pain management, and personal care. Serving 225 customers, including 44 international clients across 18 countries, the company operates on a B2B model, selling directly, through its US subsidiary, or via third-party agents. As of March 31, 2025, it employs 13 in-house R&D scientists using advanced technology to enhance its formulations.
Strengths
- Industry Reputation: Over 20 years as a top specialty ingredients maker in India.
- Product Innovation: 70 diverse products across categories, supported by active R&D.
- Customer Loyalty: Long-term clients in India and 18 other countries.
Risk factors
- Raw Material Dependence: Changes in mint or clove supply can affect production.
- Regulatory Standards: Must follow strict global rules for essential oils and derivatives.
- Competition: Faces rivals worldwide in essential oils and aroma chemicals.
Promoters
Vipul Parekh
Kaksha Vipul Parekh
Yash Vipul Parekh
Parekh Family Trust
Registrar & documents
Lead manager
Motilal Oswal Investment Advisors Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
A/410, Kailas Complex, Vikhroli Powai Link Road, Park Site, Vikhroli (W) Mumbai, Maharashtra, 400079
+91 22 25185231
[email protected]Company website ↗Understanding GEMAROMA IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.